The text introduces a new class of medication, tirzepatide, an agent that activates both GLP-1 and GIP receptors, which shows weight reduction and dominant blood glucose regulation compared to single-agonist therapies
With both the pill and the shot, people can experience side effects like nausea, constipation or diarrhea
This medicine is often recommended for individuals with nutritional deficiencies affecting the nervous system or energy metabolism
Oligo dT primers and primers for real-time PCR were obtained from Integrated DNA Technologies (IDT, Coralville, IA, USA)
Durante il successivo assorbimento intestinale il 25% circa della quota assorbita sottoposta ad acilazione direttamente in sede enterocitaria
Obesity and endothelial function